Sameer Ahmad Guru
Overview
Explore the profile of Sameer Ahmad Guru including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
68
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Huang X, Pomicter A, Ahmann J, Qiao Y, Chen O, George T, et al.
Blood Cancer J
. 2024 Oct;
14(1):179.
PMID: 39402020
No abstract available.
2.
Saha P, Guru S, Ge Z, Simms L, Chen L, Bolli R, et al.
Stem Cell Rev Rep
. 2024 Jun;
20(7):1843-1853.
PMID: 38941039
Intravenous infusion has been used as the method of cell delivery in many preclinical studies as well as in some early clinical trials. Among its advantages are broad distribution, ability...
3.
Maheswari R, Urs A, Kumar P, Koner B, Guru S, Rawat G
Mol Biol Rep
. 2024 Feb;
51(1):341.
PMID: 38400867
Introduction: Oral Squamous Cell Carcinoma (OSCC) is one of the leading cancers worldwide, significantly impacting developing nations. This study aimed to explore the diagnostic and prognostic potential of miR-155-5p and...
4.
Garg A, Urs A, Koner B, Augustine J, Guru S
Head Neck Pathol
. 2023 Nov;
17(4):961-968.
PMID: 38015343
Background: Altered levels of miRNAs might affect the pathogenesis of oral squamous cell carcinoma (OSCC) and oral potentially malignant disorders (OPMD). This study evaluated the diagnostic potential of salivary miRNA-21...
5.
Guru S, Saha P, Chen L, Tulshyan A, Ge Z, Baily J, et al.
Stem Cell Rev Rep
. 2023 Jun;
19(6):2038-2051.
PMID: 37261668
Stem cell therapy provides a hope to no option heart disease patient group. Stem cells work via different mechanisms of which paracrine mechanism is reported to justify most of the...
6.
Sinha A, Guru S, Varadarajan S, Alvarez A, Kaushal S, Fu X
Stem Cell Res
. 2023 Apr;
69:103092.
PMID: 37086582
We generated a new iPSC line (LCHi003-A) from the pediatric dilated cardiomyopathy patient carrying the de novo mutation on DNM1L gene. The new iPSC line expressed high pluripotent markers and...
7.
Mishra R, Saha P, Datla S, Mellacheruvu P, Gunasekaran M, Guru S, et al.
J Transl Med
. 2023 Mar;
21(1):168.
PMID: 36869398
No abstract available.
8.
Sophiya P, Urs D, Lone J, Giresha A, Krishna Ram H, Manjunatha J, et al.
Front Pharmacol
. 2022 Nov;
13:996285.
PMID: 36324674
Human phospholipase A group IIa (sPLAIIa) is an inflammatory enzyme that plays a significant role in tumorigenesis. Inhibiting the sPLAIIa enzyme with an effective molecule can reduce the inflammatory response...
9.
Mishra R, Saha P, Datla S, Mellacheruvu P, Gunasekaran M, Guru S, et al.
J Transl Med
. 2022 Jul;
20(1):323.
PMID: 35864544
Background: Despite promising results in clinical studies, the mechanism for the beneficial effects of allogenic cell-based therapies remains unclear. Macrophages are not only critical mediators of inflammation but also critical...
10.
Guru S, Sumi M, Mir R, Ali Beg M, Koner B, Saxena A
BMC Cancer
. 2022 Apr;
22(1):439.
PMID: 35459155
No abstract available.